Favorable outcome of experimental islet xenotransplantation without immunosuppression in a nonhuman primate model of diabetes

Barbara Ludwig; Stefan Ludwig; Anja Steffen; Yvonne Knauf; Baruch Zimerman; Sophie Heinke; Susann Lehmann; Undine Schubert; Janine Schmid; Martina Bleyer; Uwe Schönmann; Clark K. Colton; Ezio Bonifacio; Michele Solimena; Andreas Reichel; Andrew V. Schally; Avi Rotem; Uriel Barkai; Helena Grinberg-Rashi; Franz Josef Kaup; Yuval Avni; Peter Jones; Stefan R. Bornstein

doi:10.1073/pnas.1708420114

Favorable outcome of experimental islet xenotransplantation without immunosuppression in a nonhuman primate model of diabetes

Barbara Ludwig, Stefan Ludwig, Anja Steffen, Yvonne Knauf, Baruch Zimerman, Sophie Heinke, Susann Lehmann, Undine Schubert, Janine Schmid, Martina Bleyer, Uwe Schönmann, Clark K. Colton, Ezio Bonifacio, Michele Solimena, Andreas Reichel, Andrew V. Schally, Avi Rotem, Uriel Barkai, Helena Grinberg-Rashi, Franz Josef KaupYuval Avni, Peter Jones, Stefan R. Bornstein

Pathology

Research output: Contribution to journal › Article

30 Scopus citations

Abstract

Transplantation of pancreatic islets for treating type 1 diabetes is restricted to patients with critical metabolic lability resulting from the need for immunosuppression and the shortage of donor organs. To overcome these barriers, we developed a strategy to macroencap-sulate islets from different sources that allow their survival and function without immunosuppression. Here we report successful and safe transplantation of porcine islets with a bioartificial pancreas device in diabetic primates without any immune suppression. This strategy should lead to pioneering clinical trials with xenotransplantation for treatment of diabetes and, thereby, represents a previously unidentified approach to efficient cell replacement for a broad spectrum of endocrine disorders and other organ dysfunctions.

Original language	English (US)
Pages (from-to)	11745-11750
Number of pages	6
Journal	Proceedings of the National Academy of Sciences of the United States of America
Volume	114
Issue number	44
DOIs	https://doi.org/10.1073/pnas.1708420114
State	Published - Oct 31 2017

Keywords

Beta-cell replacement
Diabetes
Immune barrier
Porcine islets

ASJC Scopus subject areas

General

Access to Document

10.1073/pnas.1708420114

Fingerprint Dive into the research topics of 'Favorable outcome of experimental islet xenotransplantation without immunosuppression in a nonhuman primate model of diabetes'. Together they form a unique fingerprint.

Cite this

Ludwig, B., Ludwig, S., Steffen, A., Knauf, Y., Zimerman, B., Heinke, S., Lehmann, S., Schubert, U., Schmid, J., Bleyer, M., Schönmann, U., Colton, C. K., Bonifacio, E., Solimena, M., Reichel, A., Schally, A. V., Rotem, A., Barkai, U., Grinberg-Rashi, H., ... Bornstein, S. R. (2017). Favorable outcome of experimental islet xenotransplantation without immunosuppression in a nonhuman primate model of diabetes. Proceedings of the National Academy of Sciences of the United States of America, 114(44), 11745-11750. https://doi.org/10.1073/pnas.1708420114

Favorable outcome of experimental islet xenotransplantation without immunosuppression in a nonhuman primate model of diabetes. / Ludwig, Barbara; Ludwig, Stefan; Steffen, Anja; Knauf, Yvonne; Zimerman, Baruch; Heinke, Sophie; Lehmann, Susann; Schubert, Undine; Schmid, Janine; Bleyer, Martina; Schönmann, Uwe; Colton, Clark K.; Bonifacio, Ezio; Solimena, Michele; Reichel, Andreas; Schally, Andrew V.; Rotem, Avi; Barkai, Uriel; Grinberg-Rashi, Helena; Kaup, Franz Josef; Avni, Yuval; Jones, Peter; Bornstein, Stefan R.

In: Proceedings of the National Academy of Sciences of the United States of America, Vol. 114, No. 44, 31.10.2017, p. 11745-11750.

Research output: Contribution to journal › Article

Ludwig, B, Ludwig, S, Steffen, A, Knauf, Y, Zimerman, B, Heinke, S, Lehmann, S, Schubert, U, Schmid, J, Bleyer, M, Schönmann, U, Colton, CK, Bonifacio, E, Solimena, M, Reichel, A, Schally, AV, Rotem, A, Barkai, U, Grinberg-Rashi, H, Kaup, FJ, Avni, Y, Jones, P & Bornstein, SR 2017, 'Favorable outcome of experimental islet xenotransplantation without immunosuppression in a nonhuman primate model of diabetes', Proceedings of the National Academy of Sciences of the United States of America, vol. 114, no. 44, pp. 11745-11750. https://doi.org/10.1073/pnas.1708420114

Ludwig, Barbara ; Ludwig, Stefan ; Steffen, Anja ; Knauf, Yvonne ; Zimerman, Baruch ; Heinke, Sophie ; Lehmann, Susann ; Schubert, Undine ; Schmid, Janine ; Bleyer, Martina ; Schönmann, Uwe ; Colton, Clark K. ; Bonifacio, Ezio ; Solimena, Michele ; Reichel, Andreas ; Schally, Andrew V. ; Rotem, Avi ; Barkai, Uriel ; Grinberg-Rashi, Helena ; Kaup, Franz Josef ; Avni, Yuval ; Jones, Peter ; Bornstein, Stefan R. / Favorable outcome of experimental islet xenotransplantation without immunosuppression in a nonhuman primate model of diabetes. In: Proceedings of the National Academy of Sciences of the United States of America. 2017 ; Vol. 114, No. 44. pp. 11745-11750.

@article{2bae0a8e8fe544d3893ba0535b10ea72,

title = "Favorable outcome of experimental islet xenotransplantation without immunosuppression in a nonhuman primate model of diabetes",

abstract = "Transplantation of pancreatic islets for treating type 1 diabetes is restricted to patients with critical metabolic lability resulting from the need for immunosuppression and the shortage of donor organs. To overcome these barriers, we developed a strategy to macroencap-sulate islets from different sources that allow their survival and function without immunosuppression. Here we report successful and safe transplantation of porcine islets with a bioartificial pancreas device in diabetic primates without any immune suppression. This strategy should lead to pioneering clinical trials with xenotransplantation for treatment of diabetes and, thereby, represents a previously unidentified approach to efficient cell replacement for a broad spectrum of endocrine disorders and other organ dysfunctions.",

keywords = "Beta-cell replacement, Diabetes, Immune barrier, Porcine islets",

author = "Barbara Ludwig and Stefan Ludwig and Anja Steffen and Yvonne Knauf and Baruch Zimerman and Sophie Heinke and Susann Lehmann and Undine Schubert and Janine Schmid and Martina Bleyer and Uwe Sch{\"o}nmann and Colton, {Clark K.} and Ezio Bonifacio and Michele Solimena and Andreas Reichel and Schally, {Andrew V.} and Avi Rotem and Uriel Barkai and Helena Grinberg-Rashi and Kaup, {Franz Josef} and Yuval Avni and Peter Jones and Bornstein, {Stefan R.}",

year = "2017",

month = oct,

day = "31",

doi = "10.1073/pnas.1708420114",

language = "English (US)",

volume = "114",

pages = "11745--11750",

journal = "Proceedings of the National Academy of Sciences of the United States of America",

issn = "0027-8424",

publisher = "National Academy of Sciences",

number = "44",

}

TY - JOUR

T1 - Favorable outcome of experimental islet xenotransplantation without immunosuppression in a nonhuman primate model of diabetes

AU - Ludwig, Barbara

AU - Ludwig, Stefan

AU - Steffen, Anja

AU - Knauf, Yvonne

AU - Zimerman, Baruch

AU - Heinke, Sophie

AU - Lehmann, Susann

AU - Schubert, Undine

AU - Schmid, Janine

AU - Bleyer, Martina

AU - Schönmann, Uwe

AU - Colton, Clark K.

AU - Bonifacio, Ezio

AU - Solimena, Michele

AU - Reichel, Andreas

AU - Schally, Andrew V.

AU - Rotem, Avi

AU - Barkai, Uriel

AU - Grinberg-Rashi, Helena

AU - Kaup, Franz Josef

AU - Avni, Yuval

AU - Jones, Peter

AU - Bornstein, Stefan R.

PY - 2017/10/31

Y1 - 2017/10/31

N2 - Transplantation of pancreatic islets for treating type 1 diabetes is restricted to patients with critical metabolic lability resulting from the need for immunosuppression and the shortage of donor organs. To overcome these barriers, we developed a strategy to macroencap-sulate islets from different sources that allow their survival and function without immunosuppression. Here we report successful and safe transplantation of porcine islets with a bioartificial pancreas device in diabetic primates without any immune suppression. This strategy should lead to pioneering clinical trials with xenotransplantation for treatment of diabetes and, thereby, represents a previously unidentified approach to efficient cell replacement for a broad spectrum of endocrine disorders and other organ dysfunctions.

AB - Transplantation of pancreatic islets for treating type 1 diabetes is restricted to patients with critical metabolic lability resulting from the need for immunosuppression and the shortage of donor organs. To overcome these barriers, we developed a strategy to macroencap-sulate islets from different sources that allow their survival and function without immunosuppression. Here we report successful and safe transplantation of porcine islets with a bioartificial pancreas device in diabetic primates without any immune suppression. This strategy should lead to pioneering clinical trials with xenotransplantation for treatment of diabetes and, thereby, represents a previously unidentified approach to efficient cell replacement for a broad spectrum of endocrine disorders and other organ dysfunctions.

KW - Beta-cell replacement

KW - Diabetes

KW - Immune barrier

KW - Porcine islets

UR - http://www.scopus.com/inward/record.url?scp=85032680626&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85032680626&partnerID=8YFLogxK

U2 - 10.1073/pnas.1708420114

DO - 10.1073/pnas.1708420114

M3 - Article

C2 - 29078330

AN - SCOPUS:85032680626

VL - 114

SP - 11745

EP - 11750

JO - Proceedings of the National Academy of Sciences of the United States of America

JF - Proceedings of the National Academy of Sciences of the United States of America

SN - 0027-8424

IS - 44

ER -